CARLOMAGNO, Chiara
CARLOMAGNO, Chiara
DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA
First-line systemic therapy for metastatic breast cancer and management of pleural effusion.
1995 F., Perrone; Carlomagno, Chiara; DE PLACIDO, Sabino; Lauria, Rossella; A., Morabito; Bianco, ANGELO RAFFAELE
Metastasis of colon cancer to the thyroid gland: a case diagnosed on fine-needle aspirate by a combined cytological, immunocytochemical and molecular approach.
2010 Immacolata, Cozzolino; Malapelle, Umberto; Carlomagno, Chiara; Palombini, Lucio; Troncone, Giancarlo
Predictive factors of complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer
2010 Carlomagno, Chiara; Stefano, Pepe; D'Armiento, FRANCESCO PAOLO; D'Armiento, Maria; Lucia, Cannella; DE STEFANO, Alfonso; Anna, Crispo; Marcella, Giordano; DE PLACIDO, Sabino
Raltitrexed versus standard leucovorin-modulated 5Fluorouracil: results form the randomized phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1).
2008 Popov, I; Carrato, A; Sobrero, A; Vincent, M; Kerr, D; Labianca, R; Bianco, Ar; El Serafi, M; Bedenne, L; Paillot, B; Mini, E; Sanches, E; Welch, J; Colette, L; Praet, M; Wils, J; Carlomagno, Chiara
Measurement of neovascularization is an independent prognosticator of survival in node-negative breast cancer patients with long-lerm follow-up.
1999 DE PLACIDO, Sabino; Carlomagno, Chiara; Ciardiello, F; DE LAURENTIIS, Michelino; Pepe, Stefano; Ruggiero, A; Tortora, Giampaolo; Panico, L; D’ ANTONIO, A; Pettinato, Guido; Petrella, Giuseppe; Bianco, Ar
A specific miRNA signature correlates with complete pathological response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer
2012 DELLA VITTORIA SCARPATI, Giuseppina; Falcetta, Francesca; Carlomagno, Chiara; Ubezio, Paolo; Marchini, Sergio; DE STEFANO, Alfonso; Singh Vijay, Kumar; D’Incalci, Maurizio; DE PLACIDO, Sabino; Pepe, Stefano
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.
2011 Mcgale, P; Correa, C; Taylor, C; Arriagada, R; Clarke, M; Cutter, D; Davies, C; Ewertz, M; Godwin, J; Gray, R; Pierce, L; Whelan, T; Wang, Y; Peto, R; Early Breast Cancer Trialists' Collaborative, Group; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Carlomagno, Chiara
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
2010 Correa, C; Mcgale, P; Taylor, C; Wang, Y; Clarke, M; Davies, C; Peto, R; Bijker, N; Solin, L; Darby, S; Early Breast Cancer Trialists' Collaborative, Group; DE LAURENTIIS, Michelino; Carlomagno, Chiara; DE PLACIDO, Sabino
Surgery in lung cancer metastasis
2009 Carlomagno, Chiara; Ca, Cella; DE STEFANO, Alfonso; L., Cannella; S., Alfieri; M., Colantuoni; DE PLACIDO, Sabino
MULTIPLE PRIMARY MALIGNANT NEOPLASM AND FAMILIAR ANAMNESIS
2009 M., Colantuoni; Carlomagno, Chiara; L., Cannella; S., Alfieri; DE STEFANO, Alfonso; Ca, Cella; DE PLACIDO, Sabino
Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial
2007 T., Suter; M., Procter; DJ Van, Veldhuisen; M., Muscholl; J., Bergh; Carlomagno, Chiara; T., Perren; R., Passalacqua; C., Bighin; J., Klijn; Ft, Ageev; E., Hiltre; J., Groetez; H., Iwata; M., Knap; M., Gnant; S., Muehlbauer; A., Spence; Rd, Gelber; MJ Piccart, Gebhart
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.
2005 Howell, A; Cuzick, J; Baum, M; Buzdar, A; Dowsett, M; Forbes, Jf; Hoctin Boes, G; Houghton, J; Locker, Gy; Tobias, Js; ATAC Trialists', Group; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Carlomagno, Chiara
MicroRNA profiling as predictive factor of complete pathological response to neoadjuvant chemoradiothetapy in patients with locally advanced cancer
2011 G., Della Vittoria Scarpati; DE STEFANO, Alfonso; F., Falcetta; Carlomagno, Chiara; P., Ubezio; S., Marchini; M., D'Incalci; DE PLACIDO, Sabino; S., Pepe
Phase I-II study of xelox and bevacizumab plus erlotinib in sequential combination (XELOX-TARAV) in first line colorectal cancer: run in part
2007 G., Tortora; Carlomagno, Chiara; Bianco, Roberto; Daniele, G; Pepe, S; Leopardo, D; Marciano, Roberta; DE LAURENTIIS, Michelino; F., Ciardiello; DE PLACIDO, Sabino
Double complete response in MCRC patient
2009 DE STEFANO, Alfonso; Carlomagno, Chiara; L., Cannella; S., Alfieri; M., Colantuoni; Ca, Cella; DE PLACIDO, Sabino
A phase II study of beweekly oxaliplatin plus infusional 5fluorouracil and folinic acid (FOLFOX4) as first-line treatment of advenced gastric cancer patients
2004 F., De Vita; M., Orditura; Matano, Elide; Bianco, Roberto; Carlomagno, Chiara; S., Infusino; Damiano, Vincenzo; E., Simeone; Mr, Diadema; E., Lieto; P., Castellano; S., Pepe; DE PLACIDO, Sabino; G., Galizia; F., Ciardiello; G., Catalano; Ar, Bianco
Bevacizumab-induced hypertension is a predictive marker of response and progression free survival in patients treated for metastatic colorectal cancer
2009 DE STEFANO, Alfonso; Carlomagno, Chiara; L., Cannella; A., Crispo; S., Pepe; S., Alfieri; M., Colantuoni; Ac, Cella; L., Raimondo; DE PLACIDO, Sabino
Weekly docetaxel and capecitabine in the treatment of advanced gastric cancer: a phase II study
2006 M., Orditura; G., Aurilio; G., Galizia; Carlomagno, Chiara; E., Lieto; L., Vecchione; E., Martinelli; DE PLACIDO, Sabino; G., Catalano; F., Ciardiello; F., De Vita
HER2 as predictive marker of resistance to endocrine treatment for advanced bresat cancer: a metanalysis of published studies
2002 DE LAURENTIIS, Michelino; Arpino, Grazia; E., Massarelli; A., Ruggiero; Carlomagno, Chiara; G., Tortora; F., Ciardiello; Ar, Bianco
Adjuvant treatment for locally advanced rectal cancer patients after pre-operative chemoradiotherapy: when, and for whom?
2014 DE STEFANO, Alfonso; Moretto, R; Bucci, Luigi; Pepe, S; Romano, Fj; Cella, Ca; Attademo, L; Rosanova, M; De Falco, S; Fiore, G; Raimondo, L; DE PLACIDO, Sabino; Carlomagno, Chiara
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| First-line systemic therapy for metastatic breast cancer and management of pleural effusion. | 1.1 Articolo in rivista | 1995 | F., Perrone; Carlomagno, Chiara; DE PLACIDO, Sabino; Lauria, Rossella; A., Morabito; Bianco, ANGELO RAFFAELE | |
| Metastasis of colon cancer to the thyroid gland: a case diagnosed on fine-needle aspirate by a combined cytological, immunocytochemical and molecular approach. | 1.1 Articolo in rivista | 2010 | Immacolata, Cozzolino; Malapelle, Umberto; Carlomagno, Chiara; Palombini, Lucio; Troncone, Giancarlo | |
| Predictive factors of complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer | 1.1 Articolo in rivista | 2010 | Carlomagno, Chiara; Stefano, Pepe; D'Armiento, FRANCESCO PAOLO; D'Armiento, Maria; Lucia, Cannella; DE STEFANO, Alfonso; Anna, Crispo; Marcella, Giordano; DE PLACIDO, Sabino | |
| Raltitrexed versus standard leucovorin-modulated 5Fluorouracil: results form the randomized phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1). | 1.1 Articolo in rivista | 2008 | Popov, I; Carrato, A; Sobrero, A; Vincent, M; Kerr, D; Labianca, R; Bianco, Ar; El Serafi, M; Bedenne, L; Paillot, B; Mini, E; Sanches, E; Welch, J; Colette, L; Praet, M; Wils, J; Carlomagno, Chiara | |
| Measurement of neovascularization is an independent prognosticator of survival in node-negative breast cancer patients with long-lerm follow-up. | 1.1 Articolo in rivista | 1999 | DE PLACIDO, Sabino; Carlomagno, Chiara; Ciardiello, F; DE LAURENTIIS, Michelino; Pepe, Stefano; Ruggiero, A; Tortora, Giampaolo; Panico, L; D’ ANTONIO, A; Pettinato, Guido; Petrella, Giuseppe; Bianco, Ar | |
| A specific miRNA signature correlates with complete pathological response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer | 1.1 Articolo in rivista | 2012 | DELLA VITTORIA SCARPATI, Giuseppina; Falcetta, Francesca; Carlomagno, Chiara; Ubezio, Paolo; Marchini, Sergio; DE STEFANO, Alfonso; Singh Vijay, Kumar; D’Incalci, Maurizio; DE PLACIDO, Sabino; Pepe, Stefano | |
| Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. | 1.1 Articolo in rivista | 2011 | Mcgale, P; Correa, C; Taylor, C; Arriagada, R; Clarke, M; Cutter, D; Davies, C; Ewertz, M; Godwin, J; Gray, R; Pierce, L; Whelan, T; Wang, Y; Peto, R; Early Breast Cancer Trialists' Collaborative, Group; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Carlomagno, Chiara | |
| Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. | 1.1 Articolo in rivista | 2010 | Correa, C; Mcgale, P; Taylor, C; Wang, Y; Clarke, M; Davies, C; Peto, R; Bijker, N; Solin, L; Darby, S; Early Breast Cancer Trialists' Collaborative, Group; DE LAURENTIIS, Michelino; Carlomagno, Chiara; DE PLACIDO, Sabino | |
| Surgery in lung cancer metastasis | 1.5 Abstract in rivista | 2009 | Carlomagno, Chiara; Ca, Cella; DE STEFANO, Alfonso; L., Cannella; S., Alfieri; M., Colantuoni; DE PLACIDO, Sabino | |
| MULTIPLE PRIMARY MALIGNANT NEOPLASM AND FAMILIAR ANAMNESIS | 1.5 Abstract in rivista | 2009 | M., Colantuoni; Carlomagno, Chiara; L., Cannella; S., Alfieri; DE STEFANO, Alfonso; Ca, Cella; DE PLACIDO, Sabino | |
| Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial | 1.5 Abstract in rivista | 2007 | T., Suter; M., Procter; DJ Van, Veldhuisen; M., Muscholl; J., Bergh; Carlomagno, Chiara; T., Perren; R., Passalacqua; C., Bighin; J., Klijn; Ft, Ageev; E., Hiltre; J., Groetez; H., Iwata; M., Knap; M., Gnant; S., Muehlbauer; A., Spence; Rd, Gelber; MJ Piccart, Gebhart | |
| Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. | 1.1 Articolo in rivista | 2005 | Howell, A; Cuzick, J; Baum, M; Buzdar, A; Dowsett, M; Forbes, Jf; Hoctin Boes, G; Houghton, J; Locker, Gy; Tobias, Js; ATAC Trialists', Group; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Carlomagno, Chiara | |
| MicroRNA profiling as predictive factor of complete pathological response to neoadjuvant chemoradiothetapy in patients with locally advanced cancer | 1.5 Abstract in rivista | 2011 | G., Della Vittoria Scarpati; DE STEFANO, Alfonso; F., Falcetta; Carlomagno, Chiara; P., Ubezio; S., Marchini; M., D'Incalci; DE PLACIDO, Sabino; S., Pepe | |
| Phase I-II study of xelox and bevacizumab plus erlotinib in sequential combination (XELOX-TARAV) in first line colorectal cancer: run in part | 1.5 Abstract in rivista | 2007 | G., Tortora; Carlomagno, Chiara; Bianco, Roberto; Daniele, G; Pepe, S; Leopardo, D; Marciano, Roberta; DE LAURENTIIS, Michelino; F., Ciardiello; DE PLACIDO, Sabino | |
| Double complete response in MCRC patient | 1.5 Abstract in rivista | 2009 | DE STEFANO, Alfonso; Carlomagno, Chiara; L., Cannella; S., Alfieri; M., Colantuoni; Ca, Cella; DE PLACIDO, Sabino | |
| A phase II study of beweekly oxaliplatin plus infusional 5fluorouracil and folinic acid (FOLFOX4) as first-line treatment of advenced gastric cancer patients | 1.5 Abstract in rivista | 2004 | F., De Vita; M., Orditura; Matano, Elide; Bianco, Roberto; Carlomagno, Chiara; S., Infusino; Damiano, Vincenzo; E., Simeone; Mr, Diadema; E., Lieto; P., Castellano; S., Pepe; DE PLACIDO, Sabino; G., Galizia; F., Ciardiello; G., Catalano; Ar, Bianco | |
| Bevacizumab-induced hypertension is a predictive marker of response and progression free survival in patients treated for metastatic colorectal cancer | 1.5 Abstract in rivista | 2009 | DE STEFANO, Alfonso; Carlomagno, Chiara; L., Cannella; A., Crispo; S., Pepe; S., Alfieri; M., Colantuoni; Ac, Cella; L., Raimondo; DE PLACIDO, Sabino | |
| Weekly docetaxel and capecitabine in the treatment of advanced gastric cancer: a phase II study | 1.5 Abstract in rivista | 2006 | M., Orditura; G., Aurilio; G., Galizia; Carlomagno, Chiara; E., Lieto; L., Vecchione; E., Martinelli; DE PLACIDO, Sabino; G., Catalano; F., Ciardiello; F., De Vita | |
| HER2 as predictive marker of resistance to endocrine treatment for advanced bresat cancer: a metanalysis of published studies | 1.5 Abstract in rivista | 2002 | DE LAURENTIIS, Michelino; Arpino, Grazia; E., Massarelli; A., Ruggiero; Carlomagno, Chiara; G., Tortora; F., Ciardiello; Ar, Bianco | |
| Adjuvant treatment for locally advanced rectal cancer patients after pre-operative chemoradiotherapy: when, and for whom? | 1.1 Articolo in rivista | 2014 | DE STEFANO, Alfonso; Moretto, R; Bucci, Luigi; Pepe, S; Romano, Fj; Cella, Ca; Attademo, L; Rosanova, M; De Falco, S; Fiore, G; Raimondo, L; DE PLACIDO, Sabino; Carlomagno, Chiara |